Phase II study of nimotuzumab and radiotherapy in children and adolescents with newly diagnosed diffuse intrinsic pontine gliomas (DIPG) (2015)
- Authors:
- Autor USP: ODONE FILHO, VICENTE - FM
- Unidade: FM
- Subjects: NEOPLASIAS CEREBRAIS (TERAPIA); ADOLESCENTES; CRIANÇAS; RADIOTERAPIA
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2015
- Source:
- Título do periódico: Journal of Clinical Oncology
- ISSN: 0732-183X
- Volume/Número/Paginação/Ano: v. 33, n. 15S , abstr. 10061, 2015
- Conference titles: ASCO Annual Meeting
-
ABNT
EPELMAN, Sidnei et al. Phase II study of nimotuzumab and radiotherapy in children and adolescents with newly diagnosed diffuse intrinsic pontine gliomas (DIPG). Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/10061?sid=ec5521be-1bcd-4729-88fd-8af50b936997. Acesso em: 19 abr. 2024. , 2015 -
APA
Epelman, S., Odone, V., Gorender, E., Medeiros, R. S. S., & Martins, L. (2015). Phase II study of nimotuzumab and radiotherapy in children and adolescents with newly diagnosed diffuse intrinsic pontine gliomas (DIPG). Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/10061?sid=ec5521be-1bcd-4729-88fd-8af50b936997 -
NLM
Epelman S, Odone V, Gorender E, Medeiros RSS, Martins L. Phase II study of nimotuzumab and radiotherapy in children and adolescents with newly diagnosed diffuse intrinsic pontine gliomas (DIPG) [Internet]. Journal of Clinical Oncology. 2015 ; 33( 15S ):[citado 2024 abr. 19 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/10061?sid=ec5521be-1bcd-4729-88fd-8af50b936997 -
Vancouver
Epelman S, Odone V, Gorender E, Medeiros RSS, Martins L. Phase II study of nimotuzumab and radiotherapy in children and adolescents with newly diagnosed diffuse intrinsic pontine gliomas (DIPG) [Internet]. Journal of Clinical Oncology. 2015 ; 33( 15S ):[citado 2024 abr. 19 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/10061?sid=ec5521be-1bcd-4729-88fd-8af50b936997 - Aspectos clllínicos, terapêuticos e variáveis de prognostico em crianças maiores de um ano portadoras de neuroblastoma não disseminado
- Gene expression profile analysis between CD10 positive standard risk all with good and poor response to induction theraphy:: identification of potencial target genes
- Uso e abuso dos fatores de crescimento hematopoiéticos
- Segundas neoplasias em crianças com neuroblastoma
- Amegacariocitose e diabetes mellitus
- Tumor de Wilms (Nefrobastoma)
- Tumores sólidos na infância
- Câncer
- Disseminated Langerhans'cell histiocytosis and massive protein-losing enteropathy
- Estudo da expressão do gene MDR1 e MRP em pacientes pediátricos portadores de neuroblastoma
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
